(Q50856082)
Statements
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study. (English)
Howard Safran
Kevin P Charpentier
Andreas Kaubisch
Gregory Dubel
Kimberly Perez
Katherine Faricy-Anderson
Thomas Miner
Yoko Eng
Joel Victor
Angela Plette
Joseph Espat
Pamela Bakalarski
Patti Wingate
David Berz
Denise Luppe
Diane Martel
Kayla Rosati
Santiago Aparo
1 February 2015